undefined undefined
NaN.000
NaN.00%
Tonix Pharmaceuticals shares are trading lower by 7.2% Monday. The company last week announced the pricing of a $4.4 million registered direct offering.
04-01 22:43
TNX-2900 is a proprietary magnesium-potentiated formulation of intranasal oxytocin, a naturally occurring hormone that reduces appetite and eating Prader Willi syndrome is the most common genetic cause of
03-25 20:06
Tonix Pharma (TNXP) has provided an announcement. At the ACS Spring 2024 Meetin...
03-21 21:33
Tonix Pharmaceuticals (NASDAQ:TNXP) said it has selected two contract manufacturing organizations as dual supply sources for the potential launch of non-opioid pain reliever Tonmya in the US. One of t...
03-21 01:02
The latest announcement is out from Tonix Pharma (TNXP). Tonix Pharmaceuticals ...
03-20 22:02
鹤壁市市场监督管理局关于复合肥料等16种产品质量监督抽查结果的通告 近期,鹤壁市市场监督管理局组织开展了复合肥料等16种产品质量监督抽查。现将抽查有关情况通告...
01-29 17:33
Tonix Pharmaceuticals Holding Corp (NASDAQ: TNXP) shares are trading lower by 30.8% to $0.41 during Wednesday's session after the company announced it is securing up to $144 million in funding through a registered direct offering with healthcare-focused
2023-12-21 01:52
Tonix Pharmaceuticals Announces Highly Statistically Significant and Clinically...
2023-12-20 01:00
TNX-2900 is a proprietary magnesium-potentiated formulation of intranasal oxyto...
2023-12-04 08:00
Tonix's Therapeutic Development Program is Aligned with National Goal for Bette...
2023-10-25 08:45